Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.26 | 3e-05 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-05 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 9e-05 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |